Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.

Céline BéguéStellan MörnerDulce BritoChristian HengstenbergJohn G F ClelandEloisa ArbustiniEnrique GalveThomas WichterAnette RichterJean-Louis GolmardMaguy BernardOlivier DubourgMichel KomajdaPhilippe CharronRichard Isnard

Published in: Heart (British Cardiac Society) (2019)

MR-proANP emerges as a valuable biomarker for the prediction of death and heart failure related events in patients with HCM.

Keyphrases

hypertrophic cardiomyopathy
left ventricular
heart failure
cardiac resynchronization therapy
magnetic resonance
contrast enhanced
atrial fibrillation
acute heart failure
computed tomography